REV1 and melanoma: In both human and mouse cell lines, JH-RE-06, a small molecule that binds to the C-terminal domain of Rev1 and blocks interaction with the Rev7 subunit of Pol ζ, sensitised melanoma cells to cisplatin, and reduced drug-induced mutagenesis (204).